Clinical trials
Phase 2 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,430 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 8 |
| 2002 | 13 |
| 2003 | 27 |
| 2004 | 33 |
| 2005 | 47 |
| 2006 | 63 |
| 2007 | 75 |
| 2008 | 99 |
| 2009 | 103 |
| 2010 | 95 |
| 2011 | 102 |
| 2012 | 129 |
| 2013 | 85 |
| 2014 | 81 |
| 2015 | 109 |
| 2016 | 99 |
| 2017 | 98 |
| 2018 | 110 |
| 2019 | 139 |
| 2020 | 119 |
| 2021 | 185 |
| 2022 | 134 |
| 2023 | 134 |
| 2024 | 126 |
| 2025 | 130 |
| 2026 | 72 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,556 |
| Terminated | 399 |
| Recruiting | 208 |
| Active, not recruiting | 183 |
| Unknown status | 51 |
| Withdrawn | 15 |
| Not yet recruiting | 9 |
| Enrolling by invitation | 8 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 116 |
| Hoffmann-La Roche | 104 |
| AstraZeneca | 99 |
| GlaxoSmithKline | 91 |
| Novartis Pharmaceuticals | 88 |
| Janssen Research & Development, LLC | 69 |
| Eli Lilly and Company | 68 |
| Bayer | 63 |
| Sanofi | 63 |
| Bristol-Myers Squibb | 61 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 141 |
| Colitis, Ulcerative | 102 |
| Asthma | 87 |
| Carcinoma, Non-Small-Cell Lung | 87 |
| Dermatitis, Atopic | 66 |
| Diabetes Mellitus, Type 2 | 63 |
| Breast Neoplasms | 58 |
| Crohn Disease | 55 |
| Lupus Erythematosus, Systemic | 49 |
| Heart Failure | 47 |
Trials
Showing 1 to 25 of 2,430. Each trial links to its page on Pharma Observatory.
2,330 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.